Aging Population And Advancing Genomics Will Fuel Therapeutic Expansion
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
15 Aug 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$16.00
86.3% undervalued intrinsic discount15 Aug
US$2.19
1Y
12.3%7D
9.0%